North America Gene Editing Market Size & Outlook, 2026-2033

Name: North America Gene Editing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The gene editing market in North America is expected to reach a projected revenue of US$ 9,849.7 million by 2033. A compound annual growth rate of 15.8% is expected of North America gene editing market from 2026 to 2033.

Biotechnology
- Genomics & Genetic Engineering
  - Gene Editing Market Outlook

North America gene editing product outlook (Revenue, USD million, 2021-2033)
- Reagents and Consumables
- Software and Systems
- Services
North America gene editing technology outlook (Revenue, USD million, 2021-2033)
- CRISPR-Cas System
- Transcription Activator-Like Effector Nucleases (TALENs)
- Zinc Finger Nucleases (ZFNs)
- Meganucleases/Homing Endonucleases
North America gene editing end use outlook (Revenue, USD million, 2021-2033)
- Biotechnology and Pharmaceutical Companies
- University and Research Institutes
- Other

North America Gene Editing Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!